Cite
HARVARD Citation
Politz, O. et al. (n.d.). BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling‐dependent tumor growth in mouse models. International journal of cancer. 140 (2), pp. 449-459. [Online].